Clinical Trial Imaging Market by Software & Services (Operational Imaging Services, Read Analysis Services, Imaging Software), Modality (CT, MRI, X-ray, PET, Ultrasound, ECHO), End use (Pharma, Biotechnology, Contract Research Organization (CRO)), and Region (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America), Global trends and forecast from 2022 to 2029

Published on: Apr 2022
From:USD $3499.00
Number Of Pages:120

Please Choose License Type

Single User

Team User

Corporate License

Request a Sample

INTERESTED IN THIS RESEARCH?

Contact our analysts for inquiries, samples, and expert insights.

Market Size	CAGR	Dominating Region
USD 1.84 billion	7.9%	North America

by Software And Services Type	by Modality Type	by End Use
Operational Imaging Services Read Analysis Services Imaging Software	CT MRI X-Ray Pet Ultrasound Echo	Pharma Biotechnology Contact Research Organization (Cro)

4.5/5 - (21 votes)

Clinical Trial Imaging Market Overview

The global clinical trial imaging market is expected to grow at 7.9% CAGR from 2022 to 2029. It is expected to reach above USD 1.84 billion by 2029 from USD 0.92 billion in 2020.

Significant investments in research aimed at pioneering molecule development represent a key characteristic of pharmaceutical and biotechnology enterprises. The upward trajectory in both private and public sector expenditures on research and development, coupled with a growing emphasis on life science initiatives focused on innovating therapeutic and diagnostic solutions, is anticipated to have a positive impact on the global market.

Emerging economies such as India, South Korea, Brazil, and Mexico present substantial growth opportunities for stakeholders in the clinical trial imaging sector. This is chiefly attributable to the escalating investments in research and development within these nations. Additionally, these developing markets exhibit a robust trend of translating life science research into commercially viable applications. Moreover, Asian markets, particularly China and India, host numerous Contract Research Organizations (CROs) that provide drug discovery services to pharmaceutical and biotechnology firms. With the notable increase in research and development funding and the presence of CROs in emerging markets, the demand for clinical trial imaging is poised to experience significant growth in the ensuing years.

Clinical Trial Imaging Market | Exactitude Consultancy

Despite the dynamic nature of the medical imaging industry, the pharmaceutical and biotechnology sectors are witnessing sustained expansion. This is primarily attributable to heightened investment in medical imaging enterprises, as well as the occurrence of mergers and acquisitions involving the integration of state-of-the-art imaging technologies to facilitate clinical trials for medical devices.

Clinical Trial Imaging Market Segment Analysis

On the basis of software and services, the market is segmented into operational imaging services, read analysis services, imaging software. On the basis of modality, the market is bifurcated into CT, MRI, X-ray, PET, ultrasound, ECHO. Based on End Use segment, the market is segmented into Pharma, biotechnology, Contract Research Organization (CRO).

The services segment accounted for the largest share of the clinical trial imaging market in 2021, mainly due to the increase in R&D spending and growth in the pharmaceutical and biotechnology industries.

The computed tomography (CT) segment accounted for the largest share. A CT scan or computed tomography scan is a medical imaging technique used in radiology to obtain detailed internal images of the body noninvasively for diagnostic purposes. CT offers the study of drug activity and screenings for injuries, cancer (tumors), and abnormalities inside the body. In addition, factors such as increasing number of CROs, rise in R&D spending and growth in pharmaceutical and biotechnology industries drive this market.

Clinical Trial Imaging Market Players

Some of the key market players are ICON plc., BioTelemetry, Inc., Biomedical Systems Corporation, Medpace Holdings, Inc., Bioclinica Inc, Ixico PLC, Intrinsic Imaging LLC, Radiant Sage LLC, and Parexel International Corporation.

Collaborations, mergers, acquisition and new product launches were key strategies adopted by the leading players to achieve growth in the clinical trial imaging market.

In 2021, Bioclinica has developed the Image Redact AI, a new solution that would help clinical trial participants redact sensitive patient information from videos, photographs, and PDFs.
In 2021, Bioclinica has acquired Saliency. This acquisition has done to support a growing portfolio of pharmaceutical and medical device clients.
In 2021, IXICO Plc. Has signed a contract with biopharmaceutical client IXICO to provide neuroimaging services for a Phase III clinical trial under this contract.
In 2020, ERT has merged with Bioclinica. This merger will make a global leader in clinical trial technology.

Who Should Buy? Or Key stakeholders

Investors
End user companies
Research institutes
Medical sector
Environment, Health and Safety Professionals

The global clinical trial imaging market is expected to grow at 7.9% CAGR
Based on modality, the computed tomography (CT) segment accounted for the largest share.
Based on software and services, the market is segmented into operational imaging services, read analysis services, imaging software.
North America currently dominates the clinical trial imaging market.
The major trend in the Clinical Trial Imaging Market is the increasing adoption of artificial intelligence (AI) and machine learning for enhanced image analysis and interpretation.

Clinical Trial Imaging Market Regional Analysis

The global clinical trial imaging market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).

North America: includes the US, Canada, Mexico
Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN and Rest of APAC
Europe: includes UK, Germany, France, Italy, Spain, Russia, and Rest of Europe
South America: includes Brazil, Argentina and Rest of South America
Middle East & Africa: includes Turkey, UAE, Saudi Arabia, South Africa, and Rest of MEA

North America currently dominates the clinical trial imaging market because of the increased frequency of chronic diseases and the growing elderly population. This is expected to fuel regional market expansion. Aside from that, improvements in healthcare infrastructure have made it possible to diagnose and treat chronic diseases more quickly. This can be ascribed to the region’s increased R&D and the presence of significant outsourcing corporations. The market in North America is expected to be driven by a number of reasons, including an ageing population and an increase in chronic diseases. North America is the region with the most clinical trials. Furthermore, the majority of outsourcing activities originate in North America. Another element that contributes to clinical trial outsourcing to other research groups is cost.

Key Market Segments: Global Clinical Trial Imaging Market

Global Clinical Trial Imaging Market by Software And Services Type, 2020-2029, (USD Million)

Operational Imaging Services
Read Analysis Services
Imaging Software

Global Clinical Trial Imaging Market by Modality Type, 2020-2029, (USD Million)

CT
MRI
X-Ray
Pet
Ultrasound
Echo

Global Clinical Trial Imaging Market by End Use, 2020-2029, (USD Million)

Pharma
Biotechnology
Contact Research Organization (Cro)

Global Clinical Trial Imaging Market by Region, 2020-2029, (USD Million)

North America
Europe
Asia Pacific
South America
Middle East And Africa

Important Countries In All Regions Are Covered.

Key Question Answered

What are the growth opportunities related to the adoption of clinical trial imaging market across major regions in the future?
What are the new trends and advancements in the clinical trial imaging market?
Which product categories are expected to have highest growth rate in the clinical trial imaging market?
Which are the key factors driving the clinical trial imaging market?
What will the market growth rate, growth momentum or acceleration the market carries during the forecast period?

INTRODUCTION
1. MARKET DEFINITION
2. MARKET SEGMENTATION
3. RESEARCH TIMELINES
4. ASSUMPTIONS AND LIMITATIONS
RESEARCH METHODOLOGY
1. DATA MINING
  1. SECONDARY RESEARCH
  2. PRIMARY RESEARCH
  3. SUBJECT-MATTER EXPERTS’ ADVICE
2. QUALITY CHECKS
  1. FINAL REVIEW
3. DATA TRIANGULATION
  1. BOTTOM-UP APPROACH
  2. TOP-DOWN APPROACH
  3. RESEARCH FLOW
4. DATA SOURCES
EXECUTIVE SUMMARY
MARKET OVERVIEW
1. GLOBAL CLINICAL TRIAL IMAGING MARKET OUTLOOK
  1. MARKET DRIVERS
  2. MARKET RESTRAINTS
  3. MARKET OPPORTUNITIES
2. IMPACT OF COVID-19 ON GLOBAL CLINICAL TRIAL IMAGING MARKET
GLOBAL CLINICAL TRIAL IMAGING MARKET BY SOFTWARE AND SERVICES TYPE, (USD MILLION)
1. OPERATIONAL IMAGING SERVICE
2. READ ANALYSIS SERVICES
3. IMAGING SOFTWARE
GLOBAL CLINICAL TRIAL IMAGING MARKET BY MODALITY, (USD MILLION)
1. CT
2. MRI
3. X-RAY
4. PET
5. ULTRASOUND
6. ECHO
GLOBAL CLINICAL TRIAL IMAGING MARKET BY END USER, (USD MILLION)
1. PHARMA
2. BIOTECHNOLOGY
3. CONTRACT RESEARCH ORGANIZATION (CRO)
GLOBAL CLINICAL TRIAL IMAGING MARKET BY REGION, (USD MILLION)
1. INTRODUCTION
2. ASIA-PACIFIC
  1. CHINA
  2. INDIA
  3. JAPAN
  4. SOUTH KOREA
  5. AUSTRALIA
  6. SOUTH-EAST ASIA
  7. REST OF ASIA-PACIFIC
3. NORTH AMERICA
  1. UNITED STATES
  2. CANADA
  3. MEXICO
4. EUROPE
  1. GERMANY
  2. UNITED KINGDOM
  3. FRANCE
  4. ITALY
  5. SPAIN
  6. RUSSIA
  7. REST OF EUROPE
5. SOUTH AMERICA
  1. BRAZIL
  2. ARGENTINA
  3. COLOMBIA
  4. REST OF SOUTH AMERICA
6. MIDDLE- EAST AND AFRICA
  1. UAE
  2. SAUDI ARABIA
  3. SOUTH AFRICA
  4. REST OF MIDDLE- EAST AND AFRICA

COMPANY PROFILES* (BUSINESS OVERVIEW, COMPANY SNAPSHOT, PRODUCT TYPES OFFERED, RECENT DEVELOPMENTS)
1. ICON PLC.
2. BIOTELEMETRY, INC.
3. BIOMEDICAL SYSTEMS CORPORATION
4. MEDPACE HOLDINGS INC.
5. BIOCLINICA INC
6. IXICO PLC
7. INTRINSIC IMAGING LLC
8. RADIANT SAGE LLC
9. PAREXEL INTERNATIONAL CORPORATION
10. OTHERS

LIST OF TABLES

TABLE 1 GLOBAL CLINICAL TRIAL IMAGING MARKET BY SOFTWARE AND SERVICES TYPE (USD MILLIONS), 2020-2029

TABLE 2 GLOBAL CLINICAL TRIAL IMAGING MARKET BY MODALITY (USD MILLIONS), 2020-2029

TABLE 3 GLOBAL CLINICAL TRIAL IMAGING MARKET BY END USE (USD MILLIONS), 2020-2029

TABLE 4 GLOBAL CLINICAL TRIAL IMAGING MARKET BY REGION (USD MILLIONS), 2020-2029

TABLE 5 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET BY COUNTRY (USD MILLIONS), 2020-2029

TABLE 6 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET BY SOFTWARE AND SERVICES TYPE (USD MILLIONS), 2020-2029

TABLE 7 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET BY MODALITY (USD MILLIONS), 2020-2029

TABLE 8 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET BY END USE (USD MILLIONS), 2020-2029

TABLE 9 US CLINICAL TRIAL IMAGING MARKET BY SOFTWARE AND SERVICES TYPE (USD MILLIONS), 2020-2029

TABLE 10 US CLINICAL TRIAL IMAGING MARKET BY MODALITY (USD MILLIONS), 2020-2029

TABLE 11 US CLINICAL TRIAL IMAGING MARKET BY END USE (USD MILLIONS), 2020-2029

TABLE 12 CANADA CLINICAL TRIAL IMAGING MARKET BY SOFTWARE AND SERVICES TYPE (MILLIONS), 2020-2029

TABLE 13 CANADA CLINICAL TRIAL IMAGING MARKET BY MODALITY (USD MILLIONS), 2020-2029

TABLE 14 CANADA CLINICAL TRIAL IMAGING MARKET BY END USE (USD MILLIONS), 2020-2029

TABLE 15 MEXICO CLINICAL TRIAL IMAGING MARKET BY SOFTWARE AND SERVICES TYPE (USD MILLIONS), 2020-2029

TABLE 16 MEXICO CLINICAL TRIAL IMAGING MARKET BY MODALITY (USD MILLIONS), 2020-2029

TABLE 17 MEXICO CLINICAL TRIAL IMAGING MARKET BY END USE (USD MILLIONS), 2020-2029

TABLE 18 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET BY COUNTRY (USD MILLIONS), 2020-2029

TABLE 19 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET BY SOFTWARE AND SERVICES TYPE (USD MILLIONS), 2020-2029

TABLE 20 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET BY MODALITY (USD MILLIONS), 2020-2029

TABLE 21 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET BY END USE (USD MILLIONS), 2020-2029

TABLE 22 BRAZIL CLINICAL TRIAL IMAGING MARKET BY SOFTWARE AND SERVICES TYPE (USD MILLIONS), 2020-2029

TABLE 23 BRAZIL CLINICAL TRIAL IMAGING MARKET BY MODALITY (USD MILLIONS), 2020-2029

TABLE 24 BRAZIL CLINICAL TRIAL IMAGING MARKET BY END USE (USD MILLIONS), 2020-2029

TABLE 25 ARGENTINA CLINICAL TRIAL IMAGING MARKET BY SOFTWARE AND SERVICES TYPE (USD MILLIONS), 2020-2029

TABLE 26 ARGENTINA CLINICAL TRIAL IMAGING MARKET BY MODALITY (USD MILLIONS), 2020-2029

TABLE 27 ARGENTINA CLINICAL TRIAL IMAGING MARKET BY END USE (USD MILLIONS), 2020-2029

TABLE 28 COLOMBIA CLINICAL TRIAL IMAGING MARKET BY SOFTWARE AND SERVICES TYPE (USD MILLIONS), 2020-2029

TABLE 29 COLOMBIA CLINICAL TRIAL IMAGING MARKET BY MODALITY (USD MILLIONS), 2020-2029

TABLE 30 COLOMBIA CLINICAL TRIAL IMAGING MARKET BY END USE (USD MILLIONS), 2020-2029

TABLE 31 REST OF SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET BY SOFTWARE AND SERVICES TYPE (USD MILLIONS), 2020-2029

TABLE 32 REST OF SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET BY MODALITY (USD MILLIONS), 2020-2029

TABLE 33 REST OF SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET BY END USE (USD MILLIONS), 2020-2029

TABLE 34 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET BY COUNTRY (USD MILLIONS), 2020-2029

TABLE 35 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET BY SOFTWARE AND SERVICES TYPE (USD MILLIONS), 2020-2029

TABLE 36 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET BY MODALITY (USD MILLIONS), 2020-2029

TABLE 37 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET BY END USE (USD MILLIONS), 2020-2029

TABLE 38 INDIA CLINICAL TRIAL IMAGING MARKET BY SOFTWARE AND SERVICES TYPE (USD MILLIONS), 2020-2029

TABLE 39 INDIA CLINICAL TRIAL IMAGING MARKET BY MODALITY (USD MILLIONS), 2020-2029

TABLE 40 INDIA CLINICAL TRIAL IMAGING MARKET BY END USE (USD MILLIONS), 2020-2029

TABLE 41 CHINA CLINICAL TRIAL IMAGING MARKET BY SOFTWARE AND SERVICES TYPE (USD MILLIONS), 2020-2029

TABLE 42 CHINA CLINICAL TRIAL IMAGING MARKET BY MODALITY (USD MILLIONS), 2020-2029

TABLE 43 CHINA CLINICAL TRIAL IMAGING MARKET BY END USE (USD MILLIONS), 2020-2029

TABLE 44 JAPAN CLINICAL TRIAL IMAGING MARKET BY SOFTWARE AND SERVICES TYPE (USD MILLIONS), 2020-2029

TABLE 45 JAPAN CLINICAL TRIAL IMAGING MARKET BY MODALITY (USD MILLIONS), 2020-2029

TABLE 46 JAPAN CLINICAL TRIAL IMAGING MARKET BY END USE (USD MILLIONS), 2020-2029

TABLE 47 SOUTH KOREA CLINICAL TRIAL IMAGING MARKET BY SOFTWARE AND SERVICES TYPE (USD MILLIONS), 2020-2029

TABLE 48 SOUTH KOREA CLINICAL TRIAL IMAGING MARKET BY MODALITY (USD MILLIONS), 2020-2029

TABLE 49 SOUTH KOREA CLINICAL TRIAL IMAGING MARKET BY END USE (USD MILLIONS), 2020-2029

TABLE 50 AUSTRALIA CLINICAL TRIAL IMAGING MARKET BY SOFTWARE AND SERVICES TYPE (USD MILLIONS), 2020-2029

TABLE 51 AUSTRALIA CLINICAL TRIAL IMAGING MARKET BY MODALITY (USD MILLIONS), 2020-2029

TABLE 52 AUSTRALIA CLINICAL TRIAL IMAGING MARKET BY END USE (USD MILLIONS), 2020-2029

TABLE 53 SOUTH EAST ASIA CLINICAL TRIAL IMAGING MARKET BY SOFTWARE AND SERVICES TYPE (USD MILLIONS), 2020-2029

TABLE 54 SOUTH EAST ASIA CLINICAL TRIAL IMAGING MARKET BY MODALITY (USD MILLIONS), 2020-2029

TABLE 55 SOUTH EAST ASIA CLINICAL TRIAL IMAGING MARKET BY END USE (USD MILLIONS), 2020-2029

TABLE 56 REST OF ASIA PACIFIC CLINICAL TRIAL IMAGING MARKET BY SOFTWARE AND SERVICES TYPE (USD MILLIONS), 2020-2029

TABLE 57 REST OF ASIA PACIFIC CLINICAL TRIAL IMAGING MARKET BY MODALITY (USD MILLIONS), 2020-2029

TABLE 58 REST OF ASIA PACIFIC CLINICAL TRIAL IMAGING MARKET BY END USE (USD MILLIONS), 2020-2029

TABLE 59 EUROPE CLINICAL TRIAL IMAGING MARKET BY COUNTRY (USD MILLIONS), 2020-2029

TABLE 60 EUROPE CLINICAL TRIAL IMAGING MARKET BY SOFTWARE AND SERVICES TYPE (USD MILLIONS), 2020-2029

TABLE 61 EUROPE CLINICAL TRIAL IMAGING MARKET BY MODALITY (USD MILLIONS), 2020-2029

TABLE 62 EUROPE CLINICAL TRIAL IMAGING MARKET BY END USE (USD MILLIONS), 2020-2029

TABLE 63 GERMANY CLINICAL TRIAL IMAGING MARKET BY SOFTWARE AND SERVICES TYPE (USD MILLIONS), 2020-2029

TABLE 64 GERMANY CLINICAL TRIAL IMAGING MARKET BY MODALITY (USD MILLIONS), 2020-2029

TABLE 65 GERMANY CLINICAL TRIAL IMAGING MARKET BY END USE (USD MILLIONS), 2020-2029

TABLE 66 UK CLINICAL TRIAL IMAGING MARKET BY SOFTWARE AND SERVICES TYPE (USD MILLIONS), 2020-2029

TABLE 67 UK CLINICAL TRIAL IMAGING MARKET BY MODALITY (USD MILLIONS), 2020-2029

TABLE 68 UK CLINICAL TRIAL IMAGING MARKET BY END USE (USD MILLIONS), 2020-2029

TABLE 69 FRANCE CLINICAL TRIAL IMAGING MARKET BY SOFTWARE AND SERVICES TYPE (USD MILLIONS), 2020-2029

TABLE 70 FRANCE CLINICAL TRIAL IMAGING MARKET BY MODALITY (USD MILLIONS), 2020-2029

TABLE 71 FRANCE CLINICAL TRIAL IMAGING MARKET BY END USE (USD MILLIONS), 2020-2029

TABLE 72 ITALY CLINICAL TRIAL IMAGING MARKET BY SOFTWARE AND SERVICES TYPE (USD MILLIONS), 2020-2029

TABLE 73 ITALY CLINICAL TRIAL IMAGING MARKET BY MODALITY (USD MILLIONS), 2020-2029

TABLE 74 ITALY CLINICAL TRIAL IMAGING MARKET BY END USE (USD MILLIONS), 2020-2029

TABLE 75 SPAIN CLINICAL TRIAL IMAGING MARKET BY SOFTWARE AND SERVICES TYPE (USD MILLIONS), 2020-2029

TABLE 76 SPAIN CLINICAL TRIAL IMAGING MARKET BY MODALITY (USD MILLIONS), 2020-2029

TABLE 77 SPAIN CLINICAL TRIAL IMAGING MARKET BY END USE (USD MILLIONS), 2020-2029

TABLE 78 RUSSIA CLINICAL TRIAL IMAGING MARKET BY SOFTWARE AND SERVICES TYPE (USD MILLIONS), 2020-2029

TABLE 79 RUSSIA CLINICAL TRIAL IMAGING MARKET BY MODALITY (USD MILLIONS), 2020-2029

TABLE 80 RUSSIA CLINICAL TRIAL IMAGING MARKET BY END USE (USD MILLIONS), 2020-2029

TABLE 81 REST OF EUROPE CLINICAL TRIAL IMAGING MARKET BY SOFTWARE AND SERVICES TYPE (USD MILLIONS), 2020-2029

TABLE 82 REST OF EUROPE CLINICAL TRIAL IMAGING MARKET BY MODALITY (USD MILLIONS), 2020-2029

TABLE 83 REST OF EUROPE CLINICAL TRIAL IMAGING MARKET BY END USE (USD MILLIONS), 2020-2029

TABLE 84 MIDDLE EAST AND AFRICA CLINICAL TRIAL IMAGING MARKET BY COUNTRY (USD MILLIONS), 2020-2029

TABLE 85 MIDDLE EAST AND AFRICA CLINICAL TRIAL IMAGING MARKET BY SOFTWARE AND SERVICES TYPE (USD MILLIONS), 2020-2029

TABLE 86 MIDDLE EAST AND AFRICA CLINICAL TRIAL IMAGING MARKET BY MODALITY (USD MILLIONS), 2020-2029

TABLE 87 MIDDLE EAST AND AFRICA CLINICAL TRIAL IMAGING MARKET BY END USE (USD MILLIONS), 2020-2029

TABLE 88 UAE CLINICAL TRIAL IMAGING MARKET BY SOFTWARE AND SERVICES TYPE (USD MILLIONS), 2020-2029

TABLE 89 UAE CLINICAL TRIAL IMAGING MARKET BY MODALITY (USD MILLIONS), 2020-2029

TABLE 90 UAE CLINICAL TRIAL IMAGING MARKET BY END USE (USD MILLIONS), 2020-2029

TABLE 91 SAUDI ARABIA CLINICAL TRIAL IMAGING MARKET BY SOFTWARE AND SERVICES TYPE (USD MILLIONS), 2020-2029

TABLE 92 SAUDI ARABIA CLINICAL TRIAL IMAGING MARKET BY MODALITY (USD MILLIONS), 2020-2029

TABLE 93 SAUDI ARABIA CLINICAL TRIAL IMAGING MARKET BY END USE (USD MILLIONS), 2020-2029

TABLE 94 SOUTH AFRICA CLINICAL TRIAL IMAGING MARKET BY SOFTWARE AND SERVICES TYPE (USD MILLIONS), 2020-2029

TABLE 95 SOUTH AFRICA CLINICAL TRIAL IMAGING MARKET BY MODALITY (USD MILLIONS), 2020-2029

TABLE 96 SOUTH AFRICA CLINICAL TRIAL IMAGING MARKET BY END USE (USD MILLIONS), 2020-2029

TABLE 97 REST OF MIDDLE EAST AND AFRICA CLINICAL TRIAL IMAGING MARKET BY SOFTWARE AND SERVICES TYPE (USD MILLIONS), 2020-2029

TABLE 98 REST OF MIDDLE EAST AND AFRICA CLINICAL TRIAL IMAGING MARKET BY MODALITY (USD MILLIONS), 2020-2029

TABLE 99 REST OF MIDDLE EAST AND AFRICA CLINICAL TRIAL IMAGING MARKET BY END USE (USD MILLIONS), 2020-2029

LIST OF FIGURES

FIGURE 1 MARKET DYNAMICS

FIGURE 2 MARKET SEGMENTATION

FIGURE 3 REPORT TIMELINES: YEARS CONSIDERED

FIGURE 4 DATA TRIANGULATION

FIGURE 5 BOTTOM-UP APPROACH

FIGURE 6 TOP-DOWN APPROACH

FIGURE 7 RESEARCH FLOW

FIGURE 8 GLOBAL CLINICAL TRIAL IMAGING MARKET BY SOFTWARE AND SERVICES, USD MILLION, 2020-2029

FIGURE 9 GLOBAL CLINICAL TRIAL IMAGING MARKET BY MODALITY, USD MILLION, 2020-2029

FIGURE 10 GLOBAL CLINICAL TRIAL IMAGING MARKET BY END USE, USD MILLION, 2020-2029

FIGURE 10 GLOBAL CLINICAL TRIAL IMAGING MARKET BY REGION, USD MILLION, 2020-2029

FIGURE 11 PORTER’S FIVE FORCES MODEL

FIGURE 12 GLOBAL CLINICAL TRIAL IMAGING MARKET BY SOFTWARE AND SERVICES, USD MILLION, 2020-2029

FIGURE 8 GLOBAL CLINICAL TRIAL IMAGING MARKET BY MODALITY, USD MILLION, 2020-2029

FIGURE 9 GLOBAL CLINICAL TRIAL IMAGING MARKET BY END USE, USD MILLION, 2020-2029

FIGURE 10 GLOBAL CLINICAL TRIAL IMAGING MARKET BY REGION, USD MILLION, 2020-2029

FIGURE 10 CLINICAL TRIAL IMAGING MARKET BY REGION 2021

FIGURE 11 MARKET SHARE ANALYSIS

FIGURE 17 ICON PLC.: COMPANY SNAPSHOT

FIGURE 18 BIOTELEMETRY, INC.: COMPANY SNAPSHOT

FIGURE 19 BIOMEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT

FIGURE 20 MEDPACE HOLDINGS INC: COMPANY SNAPSHOT

FIGURE 21 BIOCLINICA INC: COMPANY SNAPSHOT

FIGURE 22 IXICO PLC: COMPANY SNAPSHOT

FIGURE 23 INTRINSIC IMAGING LLC: COMPANY SNAPSHOT

FIGURE 24 RADIANT SAGE LLC: COMPANY SNAPSHOT

FIGURE 25 PAREXEL INTERNATIONAL CORPORATION: COMPANY SNAPSHOT

In-Depth Database

Our Report’s database covers almost all topics of all regions over the Globe.

Recognised Publishing Sources

Tie ups with top publishers around the globe.

Customer Support

Complete pre and post sales
support.

Safe & Secure

Complete secure payment
process.

INTERESTED IN THIS RESEARCH?

REPORT OUTLOOK

SCOPE OF THE REPORT